BI
BIIB icon

Boulegeris Investments’s Biogen BIIB Stock Holding History

Boulegeris Investments’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-6,820
Closed -$1.77M – 46
2016
Q1 		$1.77M Buy
6,820
+15
+0.2% +$3.96K 1.25% 21
2015
Q4 		$2.08M Sell
6,805
-925
-12% -$266K 1.51% 19
2015
Q3 		$2.26M Buy
7,730
+525
+7% +$173K 1.73% 16
2015
Q2 		$2.91M Buy
7,205
+1,022
+17% +$410K 2.09% 16
2015
Q1 		$2.61M Buy
6,183
+1,568
+34% +$618K 1.92% 17
2014
Q4 		$1.57M Buy
4,615
+490
+12% +$159K 1.25% 23
2014
Q3 		$1.36M Buy
+4,125
New +$1.36M 1.11% 24

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Boulegeris Investments's BIIB Position: Q2 2016 in Review

Boulegeris Investments sold out of Biogen (BIIB) in Q2 2016, closing a stake of 6,820 shares — an estimated $1.77M sold.

Boulegeris Investments first reported a position in BIIB in Q3 2014 and held it in 7 quarters. The position peaked at $2.91M in Q2 2015. 965 funds tracked by Wall St. Rank hold BIIB as of Q2 2016.

  • Boulegeris Investments reported no remaining Biogen position as of Q2 2016 after selling out during the quarter.
  • Boulegeris Investments sold 6,820 Biogen shares in Q2 2016, an estimated $1.77M.
  • Boulegeris Investments first reported a position in Biogen in Q3 2014 and held it in 7 quarters.
  • Boulegeris Investments's Biogen position peaked at $2.91M in Q2 2015.
  • 965 funds tracked by Wall St. Rank held Biogen as of Q2 2016.

Based on Boulegeris Investments's 13F filing for Q2 2016, filed 12 Jul 2016.